Show simple item record

dc.creatorTailor, Imran K.
dc.creatorAlshehry, Nawal F.
dc.creatorZaidi, Syed Z.
dc.creatorMarei, Mohammed A.
dc.creatorMotabi, Ibrahim H.
dc.creatorAlfayez, Mansour
dc.creatorAltaf, Syed Y.
dc.date.accessioned2020-09-22T17:19:19Z
dc.date.available2020-09-22T17:19:19Z
dc.date.created2020
dc.identifier.issn1658-3876spa
dc.identifier.otherhttps://doi.org/10.1016/j.hemonc.2020.08.002spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/13586
dc.description.abstractPatients with haematological cancers and concurrent coronavirus disease 2019 (COVID-19) reportedly have poor outcomes as indicated by high hospitalisation rates, high case fatality rates in mechanically ventilated patients, and a high mortality rate of ≥10% [1], [2], [3]. A recent small study reported a high mortality rate among patients with myeloma and concurrent COVID-19 infection [4]. Interestingly, one large study reported that active or recent chemotherapy was not a predictor of severe disease, whereas checkpoint inhibitor therapy and age over 65 years were associated with adverse outcomes [1]. Here we describe the outcomes of three consecutive patients with myeloma and concurrent COVID-19 infection admitted at our tertiary care centre between April and June 2020, whilst on lenalidomide-based therapy, two of whom underwent autologous stem cell transplant, with at least 30 days of follow-up.spa
dc.format.extent3 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherHemonicspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectCOVID5 19spa
dc.subjectMyeloma patientsspa
dc.subjectLenalidomide-based therapyspa
dc.titleOutcome of myeloma patients with COVID5 19 on active lenalidomide-based therapy: 6 Does lenalidomide protect from severe 7 COVID-19?spa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAbierto (Texto Completo)spa
dc.identifier.doihttps://doi.org/10.1016/j.hemonc.2020.08.002spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record